Hudson River Capital Research wrote that AcelRx Pharmaceuticals Inc. (Nasdaq: ACRX) was undervalued. The stock price rose 75 cents to close at $3.15.
Analyst says AcelRx Pharmaceuticals is undervalued
July 17, 2017 at 17:55 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.